Jinhai Medical Technology Limited reported no changes in either its authorised or issued share capital for the month ended 30 April 2026, according to the company’s latest monthly return filed with Hong Kong Exchanges and Clearing Limited.
Authorised Capital and Issued Shares • Authorised share capital remained at HKD 20.00 million, comprising 8.00 billion ordinary shares with a par value of HKD 0.0025 each. • Issued share capital was unchanged at 5.29 billion ordinary shares; the company held no treasury shares.
Public-Float Status The filing confirms that the company continued to satisfy the Main Board’s minimum public-float requirement of 25 percent as at 30 April 2026.
Share-Based Incentives Under the Share Option Scheme adopted on 29 December 2023, 454.96 million options were outstanding at month-end, with no options granted, exercised, cancelled, or lapsed during the period. No new shares were issued through option exercises, and no treasury shares were transferred.
Treasury Shares and Other Instruments The company reported no treasury share transactions, warrants, convertible instruments, or other agreements that would affect share capital during the month.
Governance Confirmation The submission was signed by Company Secretary Wong Man Yiu, who attested that all required corporate and regulatory procedures were duly observed.
Comments